Literature DB >> 1770439

Non-thermal vasodilatation by radio frequency burst-type electromagnetic field radiation in the frog.

M Miura1, J Okada.   

Abstract

1. When the web of the anaesthetized Xenopus laevis was perfused with Ringer solution maintained at 20 degrees C, radio frequency (RF) burst-type electromagnetic (EM) field radiation not only dilated arterioles of the web which had been preconstricted with noradrenaline, but also dilated arterioles under non-stimulated conditions. The EM field-induced vasodilatation increased slowly and reached a plateau 60 min after the onset of radiation. After the cessation of radiation, vasodilatation remained for 10-20 min, then slowly subsided. 2. When a 10 MHz, 1 V (peak to peak) generator voltage induced a 7.3 milliGauss, 2.19 V cm-1 EM field, the vasodilatory effect was optimum when bursts were applied 50% of the total time at 10 kHz burst rate. 3. The vasodilatory effect was not secondary to dielectric heat in the web, because the EM field was too weak to have produced enough heat to dilate the arterioles and heat would have been constantly conducted away by the perfusion solution. 4. During perfusion with Ringer solution warmed to 30 degrees C, no vasodilatation was found, but perfusion with Ringer solution warmed to 35 degrees C induced only 11% vasodilatation. Perfusion with Ringer solution warmed to 37 degrees C induced irreversible vasoconstriction. The pattern of vasodilatation induced by warm Ringer solution was different from the vasodilatory effect of weak EM field radiation. 5. The extent of the vasodilatory effect was influenced by Ca2+ concentration of the perfusion medium. Under normal Ca2+ conditions arterioles dilated to 126% of the control diameter, while under Ca(2+)-free conditions arterioles dilated to 131% of the control value and under high-Ca2+ conditions (twice the normal level) arterioles dilated to 111% of the control value. This suggests that the vasodilatory effect may be caused by facilitation of Ca2+ outflow, and the extent of this flow may settle down to the equilibrium level of countercurrent flux between Ca2+ influx and outflow. 6. The vasodilatory effect was not inhibited under perfusion with Na(+)-free Ringer solution, suggesting that Na(+)-Ca2+ exchange system may not be involved in the vasodilatory effect. The vasodilatory effect was inhibited by vanadate, an inhibitor of Ca(2+)-ATPase, and was abolished by Methylene Blue, an inhibitor of guanylate cyclase. The evidence suggests that the mechanism of the vasodilatory effect may depend on an increase in Ca2+ outflow through the plasma membrane of the smooth muscle and/or an increase in Ca2+ influx into the sarcoplasmic reticulum.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1770439      PMCID: PMC1181461          DOI: 10.1113/jphysiol.1991.sp018509

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  14 in total

Review 1.  Cyclic GMP synthesis and function.

Authors:  S A Waldman; F Murad
Journal:  Pharmacol Rev       Date:  1987-09       Impact factor: 25.468

2.  A role for Ca2+ in the effect of very low frequency electromagnetic field on the blastogenesis of human lymphocytes.

Authors:  P Conti; G E Gigante; E Alesse; M G Cifone; C Fieschi; M Reale; P U Angeletti
Journal:  FEBS Lett       Date:  1985-02-11       Impact factor: 4.124

3.  Evidence for the presence in smooth muscle of two types of Ca2+-transport ATPase.

Authors:  F Wuytack; L Raeymaekers; J Verbist; H De Smedt; R Casteels
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

4.  Reduced mitogenic stimulation of human lymphocytes by extremely low frequency electromagnetic fields.

Authors:  P Conti; G E Gigante; M G Cifone; E Alesse; G Ianni; M Reale; P U Angeletti
Journal:  FEBS Lett       Date:  1983-10-03       Impact factor: 4.124

5.  Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields.

Authors:  R A Luben; C D Cain; M C Chen; D M Rosen; W R Adey
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

6.  Na-Ca exchange and tension development in arterial smooth muscle.

Authors:  H Reuter; M P Blaustein; G Haeusler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1973-03-15       Impact factor: 6.237

7.  Cyclic GMP regulation of the plasma membrane (Ca2+-Mg2+)ATPase in vascular smooth muscle.

Authors:  K Furukawa; H Nakamura
Journal:  J Biochem       Date:  1987-01       Impact factor: 3.387

8.  Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite.

Authors:  C A Gruetter; P J Kadowitz; L J Ignarro
Journal:  Can J Physiol Pharmacol       Date:  1981-02       Impact factor: 2.273

9.  Na/Ca exchange and tension development in vascular smooth muscle: effect of amiloride.

Authors:  S Bova; G Cargnelli; S Luciani
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  Cyclic GMP-dependent protein kinase stimulates the plasmalemmal Ca2+ pump of smooth muscle via phosphorylation of phosphatidylinositol.

Authors:  M Vrolix; L Raeymaekers; F Wuytack; F Hofmann; R Casteels
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

View more
  3 in total

1.  Increase in nitric oxide and cyclic GMP of rat cerebellum by radio frequency burst-type electromagnetic field radiation.

Authors:  M Miura; K Takayama; J Okada
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

2.  Biological effects of static magnetic fields on the microcirculatory blood flow in vivo: a preliminary report.

Authors:  S Ichioka; M Iwasaka; M Shibata; K Harii; A Kamiya; S Ueno
Journal:  Med Biol Eng Comput       Date:  1998-01       Impact factor: 2.602

3.  The effect of magnetic fields on wound healing: experimental study and review of the literature.

Authors:  Steven L Henry; Matthew J Concannon; Gloria J Yee
Journal:  Eplasty       Date:  2008-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.